0001209191-15-072330.txt : 20150928 0001209191-15-072330.hdr.sgml : 20150928 20150928173631 ACCESSION NUMBER: 0001209191-15-072330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150924 FILED AS OF DATE: 20150928 DATE AS OF CHANGE: 20150928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncothyreon Inc. CENTRAL INDEX KEY: 0001412067 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 260868560 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: (206) 801-2100 MAIL ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: Biomira CORP DATE OF NAME CHANGE: 20070911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KIRKMAN ROBERT L CENTRAL INDEX KEY: 0001242122 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33882 FILM NUMBER: 151128408 MAIL ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-24 0 0001412067 Oncothyreon Inc. ONTY 0001242122 KIRKMAN ROBERT L C/O ONCOTHYREON INC. 2601 FOURTH AVE., SUITE 500 SEATTLE WA 98121 1 1 0 0 President & CEO Stock Option (right to buy) 3.51 2015-09-24 4 A 0 750000 0.00 A 2023-09-24 Common Stock 750000 750000 D The option vests and is exercisable at the rate of 1/4th of the total shares on September 24, 2016 and then 1/48th of the total shares vest and are exercisable monthly thereafter, with 100% vested and exercisable on September 24, 2019. /s/ Julia M. Eastland as attorney-in-fact for Robert L. Kirkman 2015-09-27